Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trialShuo Wu, Tao Sun, Junnan Xu et al.|Trials|2020Cited by 10
Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trialShuo Wu, Tao Sun, Cui Jiang et al.|Research Square|2020Cited by 1